The Gut Microbiome and Cancer Immunotherapy: Can We Use the Gut Microbiome as a Predictive Biomarker for Clinical Response in Cancer Immunotherapy?

SIMPLE SUMMARY: The current review assessed the effects of the gut microbiome on clinical outcomes of immunotherapy and related adverse events (AEs) in cancer patients. Studies (n = 10) consistently reported that the gut microbiome prior to administering immune checkpoint inhibitors (ICIs) was assoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Byeongsang, Boyle, Frances, Pavlakis, Nick, Clarke, Stephen, Eade, Thomas, Hruby, George, Lamoury, Gillian, Carroll, Susan, Morgia, Marita, Kneebone, Andrew, Stevens, Mark, Liu, Wen, Corless, Brian, Molloy, Mark, Kong, Benjamin, Libermann, Towia, Rosenthal, David, Back, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508052/
https://www.ncbi.nlm.nih.gov/pubmed/34638308
http://dx.doi.org/10.3390/cancers13194824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508052/
https://www.ncbi.nlm.nih.gov/pubmed/34638308
http://dx.doi.org/10.3390/cancers13194824

Ejemplares similares